On Friday, Nuvation Bio Inc (NYSE: NUVB) opened lower -6.19% from the last session, before settling in for the closing price of $2.26. Price fluctuations for NUVB have ranged from $1.54 to $3.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 69.68% at the time writing. With a float of $226.75 million, this company’s outstanding shares have now reached $338.84 million.
The extent of productivity of a business whose workforce counts for 220 workers is very important to gauge. In terms of profitability, gross margin is 14.06%, operating margin of -1883.38%, and the pretax margin is -5534.21%.
Nuvation Bio Inc (NUVB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Nuvation Bio Inc is 33.36%, while institutional ownership is 48.57%. The most recent insider transaction that took place on May 02 ’25, was worth 50,024. In this transaction CHIEF MEDICAL OFFICER of this company sold 20,000 shares at a rate of $2.50, taking the stock ownership to the 12,000 shares. Before that another transaction happened on May 02 ’25, when Company’s Officer proposed sale 20,000 for $2.27, making the entire transaction worth $45,400.
Nuvation Bio Inc (NUVB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 69.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.79% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Check out the current performance indicators for Nuvation Bio Inc (NUVB). In the past quarter, the stock posted a quick ratio of 9.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 65.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
The latest stats from [Nuvation Bio Inc, NUVB] show that its last 5-days average volume of 5.23 million was superior to 3.06 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 46.59%. Additionally, its Average True Range was 0.17.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 30.29%, which indicates a significant increase from 28.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.16% in the past 14 days, which was lower than the 77.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.04, while its 200-day Moving Average is $2.43. Now, the first resistance to watch is $2.22. This is followed by the second major resistance level at $2.33. The third major resistance level sits at $2.38. If the price goes on to break the first support level at $2.06, it is likely to go to the next support level at $2.01. The third support level lies at $1.90 if the price breaches the second support level.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are currently 340,263K shares outstanding in the company with a market cap of 721.36 million. Presently, the company’s annual sales total 7,870 K according to its annual income of -567,940 K. Last quarter, the company’s sales amounted to 3,080 K and its income totaled -53,240 K.
